SCHEMBL2610334

SCHEMBL2610334

C=CC(=O)OCCOC(=O)CCC

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.62
HPGD P15428 1/20 0.62
ALDH1A1 P00352 5/20 0.57
TP53 P04637 3/20 0.57
HIF1A Q16665 3/20 0.57
HSD17B10 Q99714 1/20 0.57
CYP3A4 P08684 2/20 0.52
THRB P10828 4/20 0.51
DGKA P23743 1/20 0.48
ATM Q13315 1/20 0.41
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA1A P35348 1/20 0.38
DNM1 Q05193 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12346606 0.94 TSHR (0.68) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL10100078 0.94 TSHR (0.68) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL17912795 0.92 TSHR (0.69) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL2610332 0.92 TSHR (0.69) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL16327390 0.91 TSHR (0.68) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL28208975 0.91 TSHR (0.79) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL2610338 0.89 TSHR (0.69) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL303596 0.87 TSHR (0.67) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL17119709 0.87 TSHR (0.67) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL12346603 0.87 THRB (0.69) TSHRHPGDALDH1A1TP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180215843-A1 OPTICAL FILM, BRIGHTNESS ENHANCEMENT FILM, BACKLIGHT UNIT WITH BRIGHTNESS ENHANCEMENT FILM, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2018-08-02 US disclosed
US-9884441-B2 Electron beam curable resin composition, resin frame for reflectors, reflector, semiconductor light emitting device, and method for producing molded body DAI NIPPON PRINTING CO., LTD. (JP) 2018-02-06 US disclosed
US-9884441-B2 Electron beam curable resin composition, resin frame for reflectors, reflector, semiconductor light emitting device, and method for producing molded body DAI NIPPON PRINTING CO., LTD. (JP) 2018-02-06 US disclosed
US-20170021535-A1 ELECTRON BEAM CURABLE RESIN COMPOSITION, RESIN FRAME FOR REFLECTORS, REFLECTOR, SEMICONDUCTOR LIGHT EMITTING DEVICE, AND METHOD FOR PRODUCING MOLDED BODY DAI NIPPON PRINTING CO., LTD. (JP) 2017-01-26 US disclosed
US-20160377776-A1 REFLECTION MEMBER, PROJECTION SCREEN, COMBINER, AND HEAT SHIELD MEMBER FUJIFILM CORPORATION (JP) 2016-12-29 US disclosed
US-9481658-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2016-11-01 US disclosed
US-9481658-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2016-11-01 US disclosed
US-9316843-B2 Stereoscopic image recognition apparatus FUJIFILM CORPORATION (JP) 2016-04-19 US disclosed
US-9217887-B2 Stereoscopic image recognition apparatus FUJIFILM CORPORATION (JP) 2015-12-22 US disclosed
US-20150238597-A1 CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-08-27 US disclosed
US-20100239788-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
US-20100239788-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
US-7736834-B2 Photosensitive resin composition, photosensitive element employing it, resist pattern forming method, process for manufacturing printed circuit board and method for removing photocured product HITACHI CHEMICAL COMPANY, LTD. (JP) 2010-06-15 US disclosed
US-7736834-B2 Photosensitive resin composition, photosensitive element employing it, resist pattern forming method, process for manufacturing printed circuit board and method for removing photocured product HITACHI CHEMICAL COMPANY, LTD. (JP) 2010-06-15 US disclosed
US-20090149573-A1 SILICONE (METH)ACRYLATE PARTICLES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF EVONIK GOLDSCHMIDT GMBH (DE) 2009-06-11 US disclosed
US-7497970-B2 Chiral agent for liquid crystal, liquid crystal composition and polymer, as well as filter for optical recording medium, optical recording medium and color filter liquid for crystal FUJIFILM CORPORATION (JP) 2009-03-03 US disclosed
US-20070228325-A1 Chiral agent for liquid crystal, liquid crystal composition and polymer, as well as filter for optical recording medium, optical recording medium and color filter liquid for crystal FUJIFILM CORPORATION (JP) 2007-10-04 US disclosed
US-20070111136-A1 Photosensitive resin composition, photosensitive element employing it, resist pattern forming method, process for manufacturing printed circuit board and method for removing photocured product HITACHI CHEMICAL COMPANY, LTD. (JP) 2007-05-17 US disclosed
US-20070111136-A1 Photosensitive resin composition, photosensitive element employing it, resist pattern forming method, process for manufacturing printed circuit board and method for removing photocured product HITACHI CHEMICAL COMPANY, LTD. (JP) 2007-05-17 US disclosed
EP-0091401-A2 Process for preparing prepregs from fibres that contain cellulose using aqueous resin compositions CIBA-GEIGY AG (CH) 1983-10-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150238597-A1 CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES STT3B, STT3A, DDOST TSHR 3638/4885HPGD 1340/4885ALDH1A1 2693/4885
US-20100239788-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND PYM1, CCND2, CCNB2 TSHR 675/4885HPGD 4319/4885ALDH1A1 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.